"For the purposes of section 208 of the Corporations Act the Company considers that the engagement of PharmaVentures was under the “arm’s length terms” exception provided by section 210 of the Corporations Act."
Has the above been tested.
Ann: CDY Engages Advisers to Facilitate Divestment from Lyramid, page-44
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable